Hepatitis C in infection with recombinant strain RF2k/1b of the virus: clinical course and therapy | Zendy

Л. И. Николаева | Zendy; Г. В. Сапронов | Zendy; А.В. Колотвин | Zendy; Е И Самохвалов | Zendy; E. A. Leybman | Zendy; L. М. Samokhodskaya | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hepatitis C in infection with recombinant strain RF2k/1b of the virus: clinical course and therapy

Author(s) -

Л. И. Николаева,

Г. В. Сапронов,

А.В. Колотвин,

Е И Самохвалов,

E. A. Leybman,

L. М. Samokhodskaya

Publication year - 2014

Publication title -

epidemiology and infectious diseases

Language(s) - English

Resource type - Journals

eISSN - 2411-3026

pISSN - 1560-9529

DOI - 10.17816/eid40805

Subject(s) - recombinant dna , virology , medicine , virus , hepatitis c virus , antiviral therapy , russian federation , strain (injury) , chronic hepatitis , hepatitis , biology , biochemistry , gene , business , economic policy

Intergenotype recombinant RF2k/1b of hepatitis C virus was firstly detected in 2002 in the Russian Federation. In our study patients, infected with this recombinant, had high indices of liver fibrosis and did not achieve a sustained viral response to standard double therapy with exception of one participant. There are discussed and proposed options for treatment and diagnosis of these patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research